Corvidia
Waltham
About Corvidia
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $86.8M
- Funding stage: M&A
- Last round: Convertible Note (Mar 2020)
- Website: corvidiatx.com
- Phone: 781-205-4755
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/corvidia-9208 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.